We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
In this book we explore how different kinds of parasites affected the key civilizations that flourished across the world over the last 10,000 years. Ancient parasites can be recovered from mummies, skeletons, latrines, coprolites, and chamber pots. Analysis may involve microscopy, ELISA, proteomics, and recovery of DNA. A huge range of parasites can infect humans, ranging from helminths (worms), single-celled protozoa such as malaria and dysentery, and ectoparasites such as lice and fleas. Different parasites will have varying impact upon health depending upon the proportion of a society affected and the physiological consequences of infection upon the body. Here the concept of Disabilit-Adjusted Life Years (DALYs) is employed to estimate the health impact of parasites in past societies, and compare them. This should allow us for the first time to propose which past civilizations may have experienced the greatest health burden from the parasites affecting their populations.
We have seen that different species of parasites have markedly different impacts upon health. Some may kill their host and so reduce the population size, others cause chronic anaemia or malnutrition and so reduce their physical productivity, while the remainder may cause symptoms that reduce psychological well-being or cause no symptoms at all. If we use disability-adjusted life years to compare the impact of parasites upon different ancient civilizations, we can estimate the degree to which each were burdened by parasite infection. Using this approach would suggest that the civilizations with the heaviest health burden from parasites were (1) Egypt and Nubia; (2) Roman Empire; (3) Ancient China, Korea, and Japan; (4) South American Pacific Coast civilizations such as Maya, Moche, and Inca; and (5) the Ancient Near East. As many parasites impair the ability of labourers to complete physically arduous work, it is possible that the need for new, healthier workers to complete national infrastructure projects may have triggered military expeditions to neighbouring states to obtain prisoners to work as slaves in many of these civilizations.
The process of decision making is not linear and is affected by multiple factors, other than availability of evidence, such as political context, personal over public interests, decision makers’ accountability, relationships with stakeholders, and familiar experiences in the past. Evidence-informed decisions positively influence access, quality, efficiency, equity, and sustainability of health services, and improve transparency and accountability thereby reducing wastage, abuse, and corruption in the health system. This chapter presents six decision making tools that help policy makers and managers take evidence-informed decisions: burden of disease analysis; health technology assessment; cost-effectiveness analysis; health equity analysis; national health accounts analysis; and stakeholder analysis. The list of tools is not exhaustive, and additional tools can be explored to respond to the context and nature of the public health concern. Policymakers are not expected to know all their methodological aspects, rather they should know what tools are available, their purpose and application, strengths and limitations, and how to interpret the results in the local context.
Schizophrenia is a serious health problem worldwide. This systematic analysis aims to quantify the burden of schizophrenia at the global, regional and national levels using the Global Burden of Disease Study 2017 (GBD 2017).
Methods
We collected detailed information on the number of incidence cases, disability-adjusted life years (DALYs) and age-standardised incidence rate (ASIR) and age-standardised rate of DALYs (ASDR) during 1990–2017 from GBD 2017. The estimated annual percentage changes (EAPCs) in the ASIR and in the ASDR were calculated to quantify the temporal trends in the ASIR and ASDR of schizophrenia.
Results
Globally there were 1.13 million (95% uncertainty interval [UI] = 1.00 to 1.28) incident schizophrenia cases and 12.66 million (95% UI = 9.48 to 15.56) DALYs due to schizophrenia in 2017. The global ASIR decreased slightly from 1990 to 2017 (EAPC = −0.124, 95% UI = −0.114 to −0.135), while the ASDR was stable. The number of incident cases, DALYs, ASIR and ASDR were higher for males than for females. The incident rate and DALYs rate were highest among those aged 20–29 and 30–54 years, respectively. ASIR and ASDR were highest in East Asia in 2017, at 19.66 (95% UI = 17.72 to 22.00) and 205.23 (95% UI = 153.13 to 253.34), respectively. In 2017, the ASIR was highest in countries with a high-moderate sociodemographic index (SDI) and the ASDR was highest in high-SDI countries. We also found that the EAPC in ASDR was negatively correlated with the ASDR in 1990 (P = 0.001, ρ = −0.23).
Conclusion
The global burden of schizophrenia remains large and continues to increase, thereby increasing the burden on health-care systems. The reported findings should be useful for resource allocation and health services planning for the increasing numbers of patients with schizophrenia in ageing societies.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.